Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,242,597
-
Share change
-
-262,011
-
Total reported value
-
$31,342,000
-
Put/Call ratio
-
165%
-
Price per share
-
$2.56
-
Number of holders
-
32
-
Value change
-
-$590,067
-
Number of buys
-
9
-
Number of sells
-
13
Institutional Holders of TENAX THERAPEUTICS INC - COM (TENX) as of Q2 2016
As of 30 Jun 2016,
TENAX THERAPEUTICS INC - COM (TENX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,242,597 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, LLC, Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, Opaleye Management Inc., BAKER BROS. ADVISORS LP, COMMERZBANK AKTIENGESELLSCHAFT /FI, and EverPoint Asset Management, LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.